Cardiac involvement at presentation in patients hospitalized with COVID-19 and their outcome in a tertiary referral hospital in Northern Italy

[1]  F. Arturi,et al.  COVID-19 and elderly: beyond the respiratory drama , 2020, Internal and Emergency Medicine.

[2]  Yuan-qiang Lu,et al.  A COVID-19 patient with seven consecutive false-negative rRT-PCR results from sputum specimens , 2020, Internal and Emergency Medicine.

[3]  R. Bruno,et al.  Myocarditis in a 16-year-old boy positive for SARS-CoV-2 , 2020, The Lancet.

[4]  G. Iotti,et al.  COVID-19 kills at home: the close relationship between the epidemic and the increase of out-of-hospital cardiac arrests , 2020, European heart journal.

[5]  D. Noonan,et al.  The SARS-CoV-2 receptor, ACE-2, is expressed on many different cell types: implications for ACE-inhibitor- and angiotensin II receptor blocker-based cardiovascular therapies , 2020, Internal and Emergency Medicine.

[6]  C. Specchia,et al.  Characteristics and outcomes of patients hospitalized for COVID-19 and cardiac disease in Northern Italy , 2020, European heart journal.

[7]  G. Mancia,et al.  Renin–Angiotensin–Aldosterone System Blockers and the Risk of Covid-19 , 2020, The New England journal of medicine.

[8]  B. Prendergast,et al.  Acute myocardial injury is common in patients with COVID-19 and impairs their prognosis , 2020, Heart.

[9]  Eun Ji Kim,et al.  Presenting Characteristics, Comorbidities, and Outcomes Among 5700 Patients Hospitalized With COVID-19 in the New York City Area. , 2020, JAMA.

[10]  Binita Shah,et al.  ST-Segment Elevation in Patients with Covid-19 — A Case Series , 2020, The New England journal of medicine.

[11]  R. Cheng,et al.  COVID-19 and acute myocardial injury: the heart of the matter or an innocent bystander? , 2020, Heart.

[12]  Tao Guo,et al.  Cardiovascular Implications of Fatal Outcomes of Patients With Coronavirus Disease 2019 (COVID-19) , 2020, JAMA cardiology.

[13]  W. Gong,et al.  Association of Cardiac Injury With Mortality in Hospitalized Patients With COVID-19 in Wuhan, China. , 2020, JAMA cardiology.

[14]  M. Lipsitch,et al.  Estimating clinical severity of COVID-19 from the transmission dynamics in Wuhan, China , 2020, Nature Medicine.

[15]  J. Xiang,et al.  Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study , 2020, The Lancet.

[16]  G. Lippi,et al.  Cardiac troponin I in patients with coronavirus disease 2019 (COVID-19): Evidence from a meta-analysis , 2020, Progress in Cardiovascular Diseases.

[17]  Qiurong Ruan,et al.  Clinical predictors of mortality due to COVID-19 based on an analysis of data of 150 patients from Wuhan, China , 2020, Intensive Care Medicine.

[18]  Jing Yuan,et al.  Clinical and biochemical indexes from 2019-nCoV infected patients linked to viral loads and lung injury , 2020, Science China Life Sciences.

[19]  Yan Zhao,et al.  Clinical Characteristics of 138 Hospitalized Patients With 2019 Novel Coronavirus-Infected Pneumonia in Wuhan, China. , 2020, JAMA.

[20]  G. Gao,et al.  A Novel Coronavirus from Patients with Pneumonia in China, 2019 , 2020, The New England journal of medicine.

[21]  Y. Hu,et al.  Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China , 2020, The Lancet.

[22]  G. Corazza,et al.  Bringing complexity into clinical practice: An internistic approach. , 2019, European journal of internal medicine.

[23]  A. Jaffe,et al.  Evaluation of the Siemens ADVIA Centaur high-sensitivity cardiac troponin I assay in serum. , 2018, Clinica chimica acta; international journal of clinical chemistry.

[24]  E. Manzato,et al.  Uric acid: an old actor for a new role , 2007, Internal and emergency medicine.

[25]  Hugo A Katus,et al.  Differential diagnosis of elevated troponins , 2006, Heart.